H&B REPORT: WOMEN’S HEALTH A TOP WELLNESS TREND IN 2023

According to Holland & Barrett’s (LetterOne) Wellness Trends Report 2023, areas of particular interest to consumers this year will include:

  • Women’s wellness – a big business in 2022 – will ramp up even further, with personalised solutions and FemTech founders continuing to help lead the revolution on breaking down taboos around menopause, menstrual health, fertility and more
  • Wellness tech gets personal. From patches tracking dietary biomarkers to carbon levels in the breath determining metabolic function, the future is all about using health data for optimum health. Health tech innovation is also becoming more focused on key target groups, such as those suffering from, or at risk of, chronic conditions
  • Sleep As well as vitamin D and magnesium, newly-trending ingredients include glycine, spearmint and plant polyphenols, EGCG and l-theanine. Meanwhile, consumers are keeping orthosomnia — the worry about getting enough sleep — at bay with remedies containing lavender, chamomile and CBD. There will also be an increase in smart tech to synchronise circadian routines
  • Ayurveda Ayurvedic remedies such as ashwagandha and curcumin, combined with scientific scrutiny, are experiencing a rise in popularity 
  • Beauty from within Collagen’s status as a skin-smoothing beauty superhero is here to stay, but people are also starting to understand the broader benefits, and younger customers are using type 2 collagen supplements to keep their joints in optimal health
To read the full report, click here

Nicholas Hall Writes: Last Wednesday we held the NHC Start of the Year Meeting at our Southend-on-Sea HQ. What a pleasure after three years to have 35 team members in the room and most of the rest of our global team dialing-in. One of our main objectives was to brainstorm a new Strategic Narrative for the CHC industry, which will drive our Global Trends roadshow after the new DB6 data is published in early April. And, of course, the Strategic Narrative will be at the heart of New Paradigms for CHC 2023, which we have just scoped and which will be published in July. As usual I will write almost every word of this completely revised 4th edition, supported by what I truly believe to be the biggest and best market analysis and creative solutions team in the CHC industry – 54 out of our total headcount of 65 plus numerous network partners, associates and freelancers.

And many of the overarching issues to be discussed in New Paradigms are illustrated in the latest edition of CHC.Newsflash: women’s health, MedTech and FemTech, lifestyle products, natural remedies, sustainability and China (reviewed at a time when Dr Nouriel Roubini warns us in his latest book, Megathreats, of the dangers of deglobalisation). And even before we publish the new report, I hope to meet as many of you as possible at our April conference in London, when we will give you a sneak peek of the new Strategic Narrative.

I will be joined on stage in London by speakers from PAGB, Haleon and Perrigo, plus other industry experts, for our 33rd European CHC Conference 19-21 April. Exploring The Future Resumed, you can review the full agenda or explore group booking options by contacting elizabeth.bernos@NicholasHall.com.

Stark 2023 growth warning from IMF head

The Managing Director of the International Monetary Fund has cautioned that 2023 is going to be a “tough year”, with one-third of the world economy expected to be in recession. The three big economies, USA, EU and China, are slowing simultaneously, translating to negative trends globally. Kristalina Georgieva added in an interview with the CBS News programme Face the Nation that, while USA is most resilient and may avoid recession, the strong labour market is a “mixed blessing” as interest rates could remain tight to lower inflation.

Meanwhile, half of the EU – severely hit by the war in Ukraine – will be in recession this year and China, which in 2022 slowed dramatically because of its zero Covid policy, will slow down further (+4.4% growth in 2023 projected) as the relaxation of restrictions leads to soaring coronavirus cases. Overall, IMF forecasts that Advanced Economies will grow by 1.1% in 2023, while Emerging Market and Developing Economies will rise by 3.7%, led by India (+6.1%) but dragged down by Russia (-2.3%).

When asked what leaves her hopeful, Georgieva said: “I know when we work together, we can overcome the most dramatic challenges. In 2020, the world came together in the face of tremendous threat and was able to overcome this threat. In 2023, we have to do the same.” 

Nicholas Hall Writes: For most of 2022 I wrote in CHC.Newsflash about a market performing surprisingly well, but there was an implicit warning that the party would come to an end one day. Kristalina Georgieva, head of the IMF, has issued a stark warning of tough times ahead economically, but that is light reading compared with Nouriel Roubini’s new book, “Megathreats”, which highlights the 10 trends that imperil our future. Known by some as Dr Doom, Roubini prefers to be known as Dr Realistic, but in my estimation he is Dr Right as he called out many past mistakes with great foresight, including the debt binge that has made the global economy today almost unmanageable.

So how will these megathreats affect Consumer Health? In one sense, we are privileged as healthcare is a must-have category, and self-care will fill part of the vacuum left by the inability of healthcare providers to meet the needs of a growing and demographically-unbalanced population, about which Dr Roubini also writes persuasively. But consumers can only spend the money in their pockets, regardless of whether it is earned or borrowed, which is why I am so concerned about the future of CHC brands and why generics and private labels are now seen as the new growth segment.

I’m also concerned about the viability of retailers and even e-Commerce platforms, as the economic crisis will lower customer footfall and push up costs including the cost of borrowing, forcing thousands of outlets to close. We are already seeing that as a sub-plot of today’s global medicine shortages. Partly this is a story of unpredictable demand caused by the afterwave of the Covid-19 pandemic, but it also seems to me that the supply chain has become very fragile as companies look for ways to cut costs by reducing inventory to breaking point. So our 2023 mission here at the Nicholas Hall Group is to reassess the Strategic Narrative for Consumer Health and offer advice to clients and the industry at large on how to survive mega- and microthreats.

We are pleased to announce that experts from Haleon, Perrigo and PAGB, plus our sponsors Pharmalinea will take the stage alongside Nicholas at our 33rd European CHC Conference! See the all-new agenda here. Taking place in London on 19-21 April 2023, save with the early bird booking discount when you book your place before 19 January! For more information, or for group booking discounts and sponsorship opportunities, please contact elizabeth.bernos@NicholasHall.com.

Global social media ad revenues stall

The winter update of the MAGNA (IPG Media Brands) Global Ad Forecast predicts that media owners’ advertising revenues will reach US$833bn in 2023, up 5% vs 2022. Despite challenging economic conditions, traditional media companies (TV, audio, publishing, out-of-home) saw ad revenues grow by 2.5% this year, while digital media companies grew by 9%. This is the narrowest growth gap ever observed by MAGNA, signalling that editorial media brands remain attractive and relevant as they now combine brand safety with cross-platform reach.

Multiple factors, including plateauing reach & usage and targeting limitations (as a result of Apple’s post-iOS 14 environment), combined to cause social media advertising to stall in 2022: global sales grew by just 4.4% to US$149bn, well down on the growth rates of 20-35% observed in the previous three years. TikTok is the only social media owner to post advertising growth, while incumbent social networks suffered flat or declining ad sales, especially in Europe and North America. MAGNA expects social media advertising to accelerate only slightly in 2023 (+6.8%).

Vincent Létang, EVP, Global Market Research at MAGNA and author of the report, said: “Advertising spending slowed down in the second half of 2022 because of economic uncertainty and issues affecting digital advertising formats, but traditional editorial media managed to grow by +2.5%. The gap in growth rates with digital advertising growth (+8.9%) was the narrowest ever measured by MAGNA, suggesting that the long-term transition to a digital-centric marketing landscape has slowed down following the Covid acceleration.

Nicholas Hall Writes: “What are the ideal channels of distribution and communication post-Covid, when consumers clearly are omnivorous and want the best of all possible worlds and flexibility in choosing brands and spending their hard-won cash in this global recession? It seems that there has never been a greater need for searching questions about the validity of brand strategies and marketing execution, which is needed both within companies and in media like CHC.Newsflash.

For more information on the news service, or to set up a trial of CHC.Newsflash or CHC.NewDirections to kickstart your 2023, contact melissa.lee@NicholasHall.com.

Female-oriented A+P dominates Nicholas Hall’s APAC Awards

CHC Insight’s Senior Editor, Nicola Allan, summarises the Creative Marketing Award winners from last week’s Nicholas Hall’s APAC e-Conference:

  • Winner: Kalbe Consumer Health’s Mixagrip in Indonesia

The growth-driving campaign for Indonesia’s No.1 OTC systemic cold & flu remedy was centred around the idea that work and family pressures, climate issues and the pandemic make the “sandwich generation” tired and susceptible to illness but they cannot afford to miss a day of work. This led to the #AntiSkipHari (“No Skip Days”) initiative, which began with TV ads for Mixagrip and was expanded – in collaboration with creative company Ideacultura – with a digital video that recognises the pressure of daily responsibilities, plus offline marketing including posters on commuter trains and murals created by local artists. Kalbe’s goals were to help consumers avoid having to take time off work through illness, dispel the belief that cough & cold remedies cause drowsiness and fight back in a competitive category where rival brands focus only on TV and digital marketing

  • 2nd place: ZP Therapeutics campaign for Physiogel in the Philippines

In 2020, a year of reset and self-care owing to the onset of Covid-19, ZP Therapeutics revived Physiogel following a hiatus from the spotlight. A digital campaign shared the message that only Physiogel contains BioMimic Technology to strengthen sensitive skin and make it soft, which led to the concept of “Strength in Softness”, a celebration of the gentle strength that women possess. From this, the Physiogel sisterhood (SiS) emerged including Strong Skin Stories sessions on Facebook Live featuring influencers and skin care experts. In 2022, the campaign was expanded with the SiS Days Out programme, where women who donated empty skin care bottles to be recycled were given tickets to free Physiogel wellness & pampering events. These strategies led to consumer reach far exceeding expectations and an above-average brand engagement rate

  • 3rd place: Sanofi’s Ostelin in Australia

Australia’s dominant vitamin D brand was supported by “Ostelin Project Strong”, a campaign based on the idea that “Strong isn’t what a woman does. It’s who we are”. Sanofi partnered with visual media company Getty Images to showcase hundreds of photos of women that show a broad interpretation of women’s strength with the aim of enticing the younger generation and encouraging them to think about bone health without disenchanting the core 55+ target audience. Ostelin Project Strong, which boosted brand sales and share, also partnered with the 100 Women charity to support its mission of empowering women in various aspects of life

Nicholas Hall Writes: The Awards were of a very high standard and since we added the 5-minute case studies from companies showcasing their campaigns, the number and quality of entries have increased every year. We shortlisted four entries for online voting by delegates, not including the Special Award winner, Bayer China’s Canesten. The three campaigns shown above were worthy winners, but I’m going to give a special shout-out to a non-winner, Sanofi Korea’s Dulcolax for “K-Poop Star”. The case study showed a 360° campaign that attempts to break the taboo of constipation. Sadly we weren’t shown Dulcolax’s Tik Tok digital ads, which are some of the best I’ve ever seen, and absolutely in line with K-Pop culture as a way of reaching a younger target audience. Turning K-Pop into K-Poop is just brilliant.

Put your campaigns in the spotlight when you enter for our CHC Marketing Awards, to be presented during Nicholas Hall’s 33rd European CHC Conference in London on 19-21 April. For more information on entry criteria, or to book your place at this conference and save with the early bird booking discount, please contact elizabeth.bernos@NicholasHall.com.

Humanity hits milestone of global population of 8bn

The “Day of 8bn”, officially marked on 15th November 2022, is a milestone moment for humanity, according to the UN Population Fund, and “a testament to scientific breakthroughs and improvements in nutrition, public health and sanitation”, said UN Secretary-General António Guterres. However, it comes with worsening economic inequality and environmental damage. “Unless we bridge the yawning chasm between the global haves and have-nots, we are setting ourselves up for an 8bn-strong world filled with tensions and mistrust, crisis and conflict,” warned Guterres. Whether populations are growing or shrinking, every country must be equipped to provide good quality of life and lift up the most marginalised citizens. “We cannot rely on one-size-fits-all solutions in a world in which the median age is 41 in Europe, compared to 17 in sub-Saharan Africa,” noted UNFPA Chief, Natalia Kanem. “To succeed, all population policies must have reproductive rights at their core, invest in people and planet, and be based on solid data.” 

UN data indicates that the global fertility rate is now at 2.3 (down from 3.3 in 1990) and getting close to the “replacement rate” of 2.1, at which point the global population will stabilise (projected to be at some point between 2080 and 2100) and then decline. In the meantime, Africa is projected by the UN to drive half of the world’s population growth in the next 40 years, while India and Pakistan are projected to drive population growth in Asia.

Source: UN

Nicholas Hall Writes: So, as of last Tuesday there are 8bn of us on this tiny planet, a mixture of the comparatively wealthy and those who struggle; the enlightened and those who suffer from dictators with a big stick and a stone age mentality; and those who want to be more healthy. Eleven years ago, there were 7bn of us, and some experts are taking comfort from the fact that it will take 15 years before we become 9bn. And apparently our population will peak at 10.4bn sometime in the 2080s, always assuming that Dr Strangelove in Moscow doesn’t push the red button.

Actually, the topic of better health is one of the few with which we are almost all agreed, but it is a decades-old story of more people chasing increasingly-scarcer resources. Despite the amazing breakthroughs in new ways of treating serious diseases, self-care still has the potential to deliver more benefits to more people than any other component of the global healthcare system. Self-care is more than just OTC, of course, and improved lifestyle has a massive role to play if we can encourage more exercise, better diet and a cleaner environment. But our pills in bottles, tablets in strips, creams in tubes have so much more to offer in terms of raising standards of public health – if we can only get the message across.

Explore the factors impacting CHC across Asia during our Asia-Pacific e-Conference, taking place online this week! The event will also include the presentation of our Regional CHC Creative Marketing Award. There is still time to confirm your participation – for more information, or to register, please contact elizabeth.bernos@NicholasHall.com without delay.

CRN 2022 survey: Vitamin D in high demand

To mark World Vitamin D Day (2nd November), CRN published initial findings from its 2022 Consumer Survey on Dietary Supplements, which was conducted (in collaboration with Ipsos) in August 2022 among 3,133 US adults aged 18+ years. This includes 2,342 who report consuming dietary supplements seasonally, occasionally or regularly. The survey highlighted the Top 5 single ingredient supplements (see chart below), while also indicating that more than half of consumers (52%) who take supplements report taking a specialty supplement, the most reported of which are omega-3s, probiotics, melatonin and fibre.

CRN states that many more people could experience enhanced quality of life, as well as healthcare cost savings, if they were to follow the dietary supplement regimens discussed in the CRN Foundation Supplements to Savings report. For example, if all US adults aged 50+ years took calcium 1,000mg and vitamin D 15mcg per day, the US healthcare system could save US$17.3bn and avoid 361,507 medical events on average per year from 2022–30. “A steadily growing body of clinical research shows investing in preventive care through supplementation helps Americans avoid chronic conditions. This strategy is what we call a no-brainer,” said CRN SVP Scientific & Regulatory Affairs Andrea Wong.

Nicholas Hall Writes: As CHC.Newsflash reported recently, overall supplement usage stands at 75% of the entire US population, an astonishingly high level. Multivitamins remains the top dietary supplement (taken by 70%) and reported consumption of immunity-boosting supplements – including vitamin D, vitamin C and zinc – remains steady vs last year. Immune health is a top reason for taking supplements (40%), second only to overall health & wellness (44%). Yet there is still room for more growth, which would benefit both individual consumers and our industry, and the healthcare system at large. According to CRN, the annual savings from wider usage of calcium and vitamin D could reach US$17bn.

This data joins a torrent of basically good news about consumer health that makes me think that we are at the beginning of a golden age for our industry, which is how I described our prospects when I gave the final presentation at the Ceuta London conference. We used to say that CHC was dependent on three main drivers of growth. It is true that the cough & cold market is once again boosting demand, but we now no longer rely on the Emerging Markets to the same extent, and Rx-to-OTC is virtually non-existent. No, it is the broader acceptance of self-care by the US and European population that is delivering the most impressive results this year.

In just over two weeks, you can log on to hear from Nicholas and industry experts during our Asia-Pacific e-Conference on 23 November! Topics on the agenda include the go-to-market model, self-care collaborations and sustainability through accessibility. For more information, or to register, please contact elizabeth.bernos@NicholasHall.com without delay.

Red Bull owner Dietrich Mateschitz dies

Billionaire global businessman, Formula One figure and philanthropist Dietrich Mateschitz has died at the age of 74 years. The co-founder and 49% owner of Red Bull was working in marketing at Blendax (now owned by P&G) when he discovered Krating Daeng – the drink that would become Red Bull – while travelling in Thailand. Following a few modifications, the iconic beverage was launched in Austria in 1987 and went on to become a global market leader among energy drinks. In a statement, Red Bull noted: “In these moments, the over-riding feeling is one of sadness. But soon the sadness will make way for gratitude – gratitude for what he changed, moved, encouraged and made possible for so many individual people. We will remain connected to him respectfully and lovingly.” 

Nicholas Hall Writes: Red Bull is an outstanding marketing success, and not just because it has sold over 100bn cans worldwide since it was launched in 1987. But the story begins a lot earlier: pharmacist Chaleo Yoovidhya was the son of poor Chinese immigrants to Thailand. He set up TC Pharma which became a success with revenues of about US$300mn and a very nice business marketing stimulants in (I would have to say, boring) brown bottles labelled as Krating Daeng (Red Bull). The consumer audience consisted mainly of truck drivers who needed to stay awake at the wheel while navigating Thailand’s famous traffic jams. Chaleo always claimed that Krating Daeng was a stroke of “divine inspiration” when he launched the brand in 1976. Dietrich Mateschitz was the second “angel” to become involved in the progress of the brand. He bought a bottle to overcome jet lag during a visit to Thailand, saw the immense potential lying dormant within the brand, invested US$500,000 alongside the same amount from Chaleo, and simply reinvented Red Bull, making it an energy drink for sportspeople and other on-the-go individuals, and a sexy lifestyle product for young nightclubbers.

Chaleo died in 2012 aged anywhere between 80-90! He gave various birthdates, maybe to get more birthday presents, and was reputed to be worth US$5bn when he died. Unlike Chaleo, we can be sure of Dietrich Mateschitz’s age, but not his wealth. In 2008 Forbes estimated that Chaleo and Mateschitz were worth US$4bn, but presumably the company is worth a lot more now. I mention these eye-watering amounts just to prove that real innovation can pay back handsomely. And if you say that Red Bull is just 5 cups of flavoured coffee in a can, I think you miss the point that innovation is not just about formulation, but is the whole marketing clothing of a brand. That is especially true in consumer health, where product innovation is frankly quite limited.

And that raises another question: is Red Bull a CHC product? Well, energy is an OTC indication, and every sale of Red Bull is US1.65 (the global average price per can) not spent on, say, Berocca Boost. It remains an aim of our industry to offer consumers and retailers a non-addictive energy product with vast scale, but we are nowhere near … yet!

Join Nicholas and a group of industry experts to explore key trends impacting CHC at our Asia-Pacific e-Conference, taking place online on 23 November. The event will also include the presentation of our Regional CHC Creative Marketing Award. For more information, or to register, please contact elizabeth.bernos@NicholasHall.com.

GSCF publishes v2.0 of Self-Care Readiness Index

The Global Self-Care Federation has launched the second edition of the Self-Care Readiness Index, examining how self-care policies are being implemented across the world. Both editions, together covering 20 countries, demonstrate very clearly that there is a widespread lack of a coherent view of self-care and its benefits. The SCRI is a research and policymaking tool, which explores the key enablers of self-care in support of designing a better model for healthcare systems. It evaluates countries based on four self-care enablers – stakeholder support and adoption, consumer & patient empowerment, comprehensive self-care health policies, and the appropriate regulatory environment – supported by measurable indicators of self-care readiness. The new SCRI is available here.

This latest version of the SCRI report highlights the regulatory environment as one of the key enablers of self-care, advising countries to “focus on regulations and processes governing approval of new health products, from prescriptions to over-the-counter medications.” For example, the approval time for Rx-to-OTC switch applications can vary from as little as one month in Mexico to 11-13 months in Germany and 24-30 months in Canada.

Nicholas Hall Writes: The concept of self-care needs additional drive, which is why we support the excellent work of the Global Self-Care Federation. As GSCF Director General, Judy Stenmark, said when announcing the second edition of the Self-Care Readiness Index: “Self-care has to be a political priority for every single government across the world.”

In many respects we are pushing against an open door! The latest survey of US consumers shows that they want to live longer, but are unaware that their current lifestyles mean that the last lap of life will most likely be miserable. Our industry can help and prosper by meeting the needs of a growing and highly-demanding older population.

Trevor Gore, Founder of Maestro Consulting is part of the online presenting panel joining Nicholas for our upcoming Asia-Pacific e-Conference on 23 November, exploring Opportunities with Collaboration in the Self-Care space. For more information, or to register, please contact elizabeth.bernos@NicholasHall.com.

CRN Survey: Branded ingredients favoured by VMS consumers

The Council for Responsible Nutrition has revealed initial findings from its 2022 Consumer Survey on Dietary Supplements. The survey was conducted online in August 2022 among 3,133 US adults aged 18+ years, including 2,342 who report consuming dietary supplements seasonally, occasionally or regularly.

Liz Cummings, our Regional VP North America, reports from CRN’s Now New Next conference: 

US dietary supplement use has reverted to the pre-pandemic level of 75%, with multivitamins remaining the favourite among users. A wealth of regulation, science, economic and consumer insights was unveiled over the 3-day conference, which will be shared in future NHC publications. However, with CHC Newsflash highlighting the dynamic activity related to ingredients suppliers such as DSM, Kerry and ChromaDex, we thought it was timely to share the following results from the CRN survey: 

  • 71% of supplement users agree that they “find more confidence using supplements made with branded ingredients”
  • 62% perceived that supplements with branded ingredients cost more because they are more effective and better quality, and men were more likely to say that branded ingredients work better
  • 61% are willing to pay higher prices for branded ingredients. Adults aged under 55 years are willing to pay more for branded ingredients
Source: CRN / Ipsos

Nicholas Hall Writes: It seems we are awash with consumer research that confirms the importance of self-care, especially with regards to immunity, even though demand is returning to pre-pandemic levels. In many respects, consumers seem ahead of marketers (let alone regulators) in how they respond to the mega-trends of the day: the pandemics, economic pressures and the energy crisis.

As I wrote last week: “I see a paradox in matching this consumer U&A data with the relative failure of specific immunity products such as antiviral nasal sprays … So why is it that consumers who fear Covid-19, and who subscribe to the concept of immunity, are content to rely on, say, a multivitamin the category grew by 13.5% globally in Year 1 of the pandemic — and not divert to specialist products? I am still searching for an answer.” Another paradox is that, while the top CHC players are reporting excellent sales and the global sales data for the 12 months to June 2022 which we reported in late September is at a record high, retailers and e-Commerce platforms are reporting reduced traffic. And there are signs that many consumers are trading down to smaller packs or cheaper generics and private labels, which you would expect in a recession.

One of the joys of working in consumer health is its resilience. It truly is a “must have” category, but it is in the detail where we will make or lose our reputations. It seems that we must switch focus from macro-trends to the micro and to understand better what makes everything tick rather than the size of the clock. So, expect more springs, wheels and cogs to be presented in the autumn and winter months ahead.

Immune health is the focus of our recent Immunity hot topic report. With profiles of key brands across categories including antivirals, vitamins, foods & beverages and probiotics for immunity, our report explores the latest trends & developments, predicting likely future scenarios. To order your copy, or for further details, contact melissa.lee@NicholasHall.com.

Covid’s lasting impact on immune health perception

A report from Dutch-based health ingredients company Nutrileads highlights the fundamental change in consumer views on immune health in the wake of Covid-19. The report draws on data gathered by FMCG Gurus from surveys conducted with 45,000 consumers in 15 countries from 2019-22. Not only is immune health significantly more important to consumers, it is also perceived to have a far-reaching impact on long-term health and wellbeing.

For two-thirds of participants, immune health is their top health priority over the next 12 months – more than any other issue including digestive and heart health. In addition, 78% view poor immune health as being easily susceptible to long-term health problems, while 40% are taking a proactive approach to their immunity, even if they believe they are in good health. Consumers also expect more from immune health products; the top three claims they want to see on the product label are scientifically validated and clinically-proven (82%), multifunctional benefits (79%) and helps lead a healthy lifestyle (79%).

Comment from Nutrileads CEO, Joana Carneiro: This research shows us that the experience of living with the pandemic is likely to have a lasting effect. Consumers are more knowledgeable about immune health and place more importance on improving it on the longer term.

Nicholas Hall Writes: “The latest research gives us a better understanding of consumer perception of immunity after 2.5 years of Covid, and the sustained interest in using dietary supplements. But I still see a paradox in matching this consumer U&A data with the relative failure of specific immunity products such as antiviral nasal sprays … So why is it that consumers who fear Covid-19, and who subscribe to the concept of immunity, are content to rely on, say, a multivitamin – the category grew by 13.5% globally in Year 1 of the pandemic – and not divert to specialist products? I am still searching for an answer.”

In just over a month, you can log on to hear from Nicholas and industry experts during our Asia-Pacific e-Conference on 23 November! Topics on the agenda include the go-to-market model, self-care collaborations and sustainability through accessibility. For more information, or to register, please contact elizabeth.bernos@NicholasHall.com.